Effectiveness of Electroconvulsive Therapy for Preventing Relapse and Recurrence of Depression in Adults With Major Depressive Disorder: An Updated Meta-Analysis of Randomized Clinical Trials

被引:4
|
作者
Dar, Hassaan [1 ]
Vuthaluru, Kiranmayi [2 ]
Folajimi, Atunde [3 ]
Maheshwari, Leladher [4 ]
Shah, Jeet [5 ]
Senaratne, Mithum [6 ]
Pizzorno, Guiomarly [7 ]
Ali, Neelum [8 ]
机构
[1] Jinnah Med & Dent Coll, Res, Islamabad, Pakistan
[2] Jawaharlal Nehru Med Coll, Med, Belgaum, India
[3] NES Healthcare, Neurol, Aylesbury, England
[4] Bahria Univ, Med & Dent Coll, Med Sch, Karachi, Pakistan
[5] Sir Sayajirao Gen Hosp, Med & Surg, Ahmadabad, India
[6] Univ Ruhuna, Med, Matara, Sri Lanka
[7] Univ Carabobo, Gen Med, Orlando, FL USA
[8] Univ Hlth Sci, Internal Med, Lahore, Pakistan
关键词
meta; -analysis; recurrence; relapse; depression; electroconvulsive therapy; CONTINUATION TREATMENT; GUIDELINES; ECT; PHARMACOTHERAPY; EFFICACY; MOOD;
D O I
10.7759/cureus.35683
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present meta-analysis aimed to assess the impact of electroconvulsive therapy (ECT) in preventing the relapse and recurrence of depression in adults with major depressive disorders. The study was conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Two authors conducted a systematic search of online databases, such as PubMed, PsycINFO, and EMBASE, using keywords, such as "electroconvulsive therapy," "depressive disorders," and "recurrence." The primary outcome measure was the incidence of relapse and recurrence in adults with major depressive disorder who received ECT alone or in combination with an antidepressant medication compared to those who received antidepressant medication alone. The secondary outcome measure was the change in the Mini -Mental State Examination score from baseline to the end of the trial in both groups. A total of six articles were included in the meta-analysis. The pooled rate of recurrence in the ECT group was 28.4% compared to 30.6% in the antidepressant group, with no significant difference between the two groups (risk ratio (RR) = 0.84, 95% confidence interval (CI) = 0.65-1.10, p = 0.21). However, subgroup analysis showed that the risk of recurrence was significantly lower in patients receiving ECT with antidepressant therapy compared to the antidepressant group alone (RR = 0.65, 95% CI = 0.45-0.93, p = 0.02). On the other hand, when ECT was given alone, the risk was higher in the ECT group compared to the antidepressant group; however, the difference was not statistically significant (RR = 1.17, 95% CI = 0.79-1.75). In conclusion, the results of this meta-analysis suggest that ECT alone or in combination with an antidepressant medication does not significantly impact the incidence of recurrence in adults with major depressive disorder when compared to antidepressant medication alone.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Duloxetine and venlafaxine-XR in the treatment of major depressive disorder: A meta-analysis of randomized clinical trials
    Vis, PMJ
    van Baardewijk, M
    Einarson, TR
    ANNALS OF PHARMACOTHERAPY, 2005, 39 (11) : 1798 - 1807
  • [22] Saffron (Crocus sativus L.) and major depressive disorder:a meta-analysis of randomized clinical trials
    Heather Ann Hausenblas
    Debbie Saha
    Pamela Jean Dubyak
    Stephen Douglas Anton
    Journal of Integrative Medicine, 2013, 11 (06) : 377 - 383
  • [23] Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials
    Hausenblas, Heather Ann
    Saha, Debbie
    Dubyak, Pamela Jean
    Anton, Stephen Douglas
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2013, 11 (06): : 377 - 383
  • [24] The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Rosenblat, Joshua D.
    Kakar, Ron
    McIntyre, Roger S.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (02):
  • [25] Effectiveness of CBT and its modifications for prevention of relapse/ recurrence in depression: A systematic review and meta-analysis of randomized controlled trials
    Chen, Hongguang
    He, Qin
    Wang, Mingting
    Wang, Xing
    Pu, Changqin
    Li, Shunfei
    Li, Mengqian
    JOURNAL OF AFFECTIVE DISORDERS, 2022, 319 : 469 - 481
  • [26] The effectiveness of mindfulness yoga on patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials
    Miao, Chuyuan
    Gao, Yun
    Li, Xiaohua
    Zhou, Ying
    Chung, Joanne Wai-yee
    Smith, Graeme D.
    BMC COMPLEMENTARY MEDICINE AND THERAPIES, 2023, 23 (01)
  • [27] The effectiveness of mindfulness yoga on patients with major depressive disorder: a systematic review and meta-analysis of randomized controlled trials
    Chuyuan Miao
    Yun Gao
    Xiaohua Li
    Ying Zhou
    Joanne Wai-yee Chung
    Graeme D. Smith
    BMC Complementary Medicine and Therapies, 23
  • [28] Meta-analysis of cognitive function in vortioxetine clinical trials in major depressive disorder
    McIntyre, R.
    Harrison, J.
    Loft, H.
    Jacobson, W.
    Olsen, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S459 - S460
  • [29] The effectiveness of acupuncture therapy in patients with post-stroke depression An updated meta-analysis of randomized controlled trials
    Zhang, Xin-Yan
    Li, Yu-Xiang
    Liu, Dong-Ling
    Zhang, Bing-Yan
    Chen, Dong-Ming
    MEDICINE, 2019, 98 (22)
  • [30] Omega-3 polyunsaturated fatty acids for major depressive disorder: an updated meta-analysis of randomised clinical trials
    Mocking, R. J. T.
    Assies, J.
    Ruhe, H. G.
    Koeter, M. W. J.
    Schene, A. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S442 - S443